JNJ

HIV vaccine shows signs of cross-subtype protection
HIV vaccine shows signs of cross-subtype protection
Fierce Biotech
vaccines
HIV
ALVAC‐HIV
Sanofi Pasteur
GSK
JNJ
South Africa
clinical trials
Flag link:
EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win
EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win
Fierce Pharma
Novo Nordisk
Ozempic
JNJ
Invokana
Victoza
diabetes
EASD
Flag link:
EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
kidney disease
JNJ
EASD
Flag link:
J&J filing aims Tremfya at crowded psoriatic arthritis market
J&J filing aims Tremfya at crowded psoriatic arthritis market
Pharmaforum
JNJ
psoriatic arthritis
Tremfya
Flag link:
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Fierce Pharma
Amgen
Kyprolis
JNJ
Darzalex
Multiple Myeloma
Flag link:
J&J taps AlivaMab for multi-target antibody discovery effort
J&J taps AlivaMab for multi-target antibody discovery effort
Fierce Biotech
JNJ
AlivaMab
antibody-drug conjugate
R&D
Flag link:
Drug companies pay for exclusive access to UK genetic data
Drug companies pay for exclusive access to UK genetic data
Biopharma Dive
UK
genetic database
Amgen
AstraZeneca
JNJ
GSK
Flag link:
Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial
Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial
Pharmaforum
JNJ
Janssen
ponesimod
Sanofi
Aubagio
relapsing multiple sclerosis
Flag link:
J&J scores Spravato trial win in high-risk depression. Will doctors and payers buy in?
J&J scores Spravato trial win in high-risk depression. Will doctors and payers buy in?
Fierce Pharma
JNJ
clinical depression
high-risk depression
Spravato
physicians
payers
Flag link:
Who will be the biggest pharma players in orphan drugs?
Who will be the biggest pharma players in orphan drugs?
Pharmaforum
orphan drugs
Roche
M&A
AbbVie
JNJ
Flag link:
J&J gets Stelara okay in Europe for ulcerative colitis
J&J gets Stelara okay in Europe for ulcerative colitis
Pharmaforum
JNJ
Stelara
Janssen
Europe
Flag link:
How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?
How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?
Motley Fool
opioids
opioid crisis
JNJ
McKesson
Mallinckrodt
Teva Pharmaceutical
Purdue Pharma
Par Pharma
Actavis
Flag link:
Beset by lawsuits and criticism in U.S., opioid makers eye new market in India
Beset by lawsuits and criticism in U.S., opioid makers eye new market in India
Fierce Pharma
India
opioids
JNJ
Mundipharma
Abbott Labs
Flag link:
Trump Wants the VA to Get as Much of This Drug as It Can
Trump Wants the VA to Get as Much of This Drug as It Can
Motley Fool
veterans
JNJ
Spravato
Donald Trump
Flag link:
Mark Your Calendar For These September PDUFA Dates
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Flag link:
J&J Opioid Ruling 2019: 13 Things to Know
J&J Opioid Ruling 2019: 13 Things to Know
Yahoo/Investor Place
JNJ
opioids
opioid crisis
Oklahoma
Flag link:
J&J found liable in Oklahoma opioid case and ordered to pay $572M; pledges to appeal
J&J found liable in Oklahoma opioid case and ordered to pay $572M; pledges to appeal
Fierce Pharma
JNJ
opioids
opioid crisis
Oklahoma
Flag link:
FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade
FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade
Big Molecule Watch
Remicade
JNJ
Pfizer
antitrust
Walgreens
Kroger
Flag link:
Should J&J owe billions for Oklahoma's opioid crisis? We'll find out Monday
Should J&J owe billions for Oklahoma's opioid crisis? We'll find out Monday
Fierce Pharma
opioids
opioid crisis
JNJ
Oklahoma
Flag link:
Why Mallinckrodt and Endo International Shares Jumped Today
Why Mallinckrodt and Endo International Shares Jumped Today
Motley Fool
opioids
Mallinckrodt
Endo International
JNJ
Flag link:

Pages